VMD Sciences is expanding global access to critical veterinary medicines with the launch of its Global Veterinary Export Pharmacy and Services, as well as the introduction of VMAPs, or Veterinary Managed Access Programs.

For more than thirty years, Managed Access Programs have proved to be an essential pathway to accessing treatments in human medicine. VMD Sciences is now applying this proven approach to veterinary care worldwide, helping veterinarians address drug shortages, emerging diseases, and unmet treatment needs.

Our new Global Export Pharmacy in Lake Worth, Florida allows veterinary practices, clinics, and distributors outside the United States to access FDA and USDA approved medications through fully compliant export channels. VMD Sciences is the first company to offer global veterinarians compliant access to medicines listed on the Essential Medicines Lists from WSAVA, WVA, BROOKE, and the List of Antimicrobial Agents of Veterinary Importance from WOAH. These organizations represent over half a million veterinarians in more than 180 countries.

VMAPs offer country-specific, regulatory-compliant access to approved, branded medicines and vaccines, supporting veterinarians as they address unmet medical needs, emerging diseases, and drug shortages.